source
- Telemedicine firm begins offering GLP-1 medications to treat addictionA telemedicine company announced it will now prescribe GLP-1 class drugs to patients with substance-use disorders through its virtual platform. GLP-1 medications, originally approved for diabetes…
- Advancing New Approach Methodologies: Building Standards and Evidence to Boost Preclinical AdoptionNew Approach Methodologies (NAMs) are being hailed as a way to transform preclinical research and toxicology, but their wider use has been hampered by three key barriers: sourcing appropriate cells…